- Previous Close
23.02 - Open
22.83 - Bid 23.02 x 900
- Ask 23.03 x 800
- Day's Range
22.77 - 23.06 - 52 Week Range
17.67 - 23.55 - Volume
7,199,678 - Avg. Volume
17,355,601 - Market Cap (intraday)
44.02B - Beta (5Y Monthly) --
- PE Ratio (TTM)
40.32 - EPS (TTM)
0.57 - Earnings Date Oct 24, 2024 - Oct 28, 2024
- Forward Dividend & Yield 0.82 (3.56%)
- Ex-Dividend Date Aug 14, 2024
- 1y Target Est
22.15
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
www.kenvue.com22,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: KVUE
View MorePerformance Overview: KVUE
Trailing total returns as of 9/23/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KVUE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KVUE
View MoreValuation Measures
Market Cap
44.09B
Enterprise Value
51.68B
Trailing P/E
40.39
Forward P/E
18.66
PEG Ratio (5yr expected)
6.34
Price/Sales (ttm)
2.86
Price/Book (mrq)
4.33
Enterprise Value/Revenue
3.34
Enterprise Value/EBITDA
20.33
Financial Highlights
Profitability and Income Statement
Profit Margin
7.23%
Return on Assets (ttm)
6.97%
Return on Equity (ttm)
10.55%
Revenue (ttm)
15.48B
Net Income Avi to Common (ttm)
1.12B
Diluted EPS (ttm)
0.57
Balance Sheet and Cash Flow
Total Cash (mrq)
1.01B
Total Debt/Equity (mrq)
84.56%
Levered Free Cash Flow (ttm)
1.99B
Research Analysis: KVUE
View MoreCompany Insights: KVUE
KVUE does not have Company Insights
Research Reports: KVUE
View MoreLooking for more favorable entry point
Kenvue Technologies Inc., formerly part of Johnson & Johnson, is a pure-play consumer health company. The company has three segments: Self Care, Skin Health & Beauty, and Essential Health. Major brands include Tylenol, Nicorette, Zyrtec, Neutrogena, Aveeno, Listerine, and Band-Aid. The company has 22,000 employees. KVUE shares are a component of the S&P 500.
RatingPrice TargetMajor indices are mixed at midday. Crude oil is down 3%. Wall Street is
Major indices are mixed at midday. Crude oil is down 3%. Wall Street is waiting on the key inflation report coming tomorrow. Any surprises will not be appreciated. We expect the CPI report to show a slight tick down, meaning that inflation is tracking lower, as the Fed wants. Markets have priced in a Fed rate cut at the meeting next week.
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, Bellway builds an appealing position; Kenvue is looking fairly healthy; Rockwell engineers a most; and Rheinmetall, Disney, and New Fortress Energy.
Kenvue Earnings: Turnaround Story Begins as Investment Behind Brands Delivers Margin Growth
Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue’s brands are the global leader in their respective segment thanks to their strong brand power.
RatingPrice Target